ALK inhibitors in the treatment of advanced NSCLC von Gridelli, Cesare, Peters, Solange, Sgambato, Assunta, Casaluce, Francesca, Adjei, Alex A, Ciardiello, Fortunato

Volltext

Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application von Maione, Paolo, Sacco, Paola Claudia, Sgambato, Assunta, Casaluce, Francesca, Rossi, Antonio, Gridelli, Cesare

Volltext

ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC von Casaluce, Francesca, Sgambato, Assunta, Maione, Paolo, Rossi, Antonio, Ferrara, Carmine, Napolitano, Alba, Palazzolo, Giovanni, Ciardiello, Fortunato, Gridelli, Cesare

Volltext

ALK inhibitors and advanced non-small cell lung cancer (Review) von ROSSI, ANTONIO, MAIONE, PAOLO, SACCO, PAOLA CLAUDIA, SGAMBATO, ASSUNTA, CASALUCE, FRANCESCA, FERRARA, MARIANNA LUCIANA, PALAZZOLO, GIOVANNI, CIARDIELLO, FORTUNATO, GRIDELLI, CESARE

Volltext

Critical points in the management of EGFR-mutated non-small cell lung cancer von Casaluce, Francesca, Gridelli, Cesare

Volltext

Frontline immunotherapy for NSCLC: alone or not alone? von Gridelli, Cesare, Casaluce, Francesca

Volltext

Narrative review of lung cancer treatment at the time of COVID-19 pandemia: pitfall and issues von Casaluce, Francesca, Gridelli, Cesare

Volltext

The adjuvant regimen for resected EGFR mutated patients: the "same-for-all-therapy" or not? von Gridelli, Cesare, Casaluce, Francesca

Volltext

The combination strategies will be ready the right first-line choice for squamous lung cancer patients? von Gridelli, Cesare, Casaluce, Francesca

Volltext

Immunotherapies in the management of epidermal growth factor receptor mutated non-small cell lung cancer: a role will be found? von Casaluce, Francesca, Gridelli, Cesare

Volltext

Lung cancer, elderly and immune checkpoint inhibitors von Casaluce, Francesca, Sgambato, Assunta, Maione, Paolo, Spagnuolo, Alessia, Gridelli, Cesare

Volltext

Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology von Gridelli, Cesare, Ardizzoni, Andrea, Barberis, Massimo, Cappuzzo, Federico, Casaluce, Francesca, Danesi, Romano, Troncone, Giancarlo, De Marinis, Filippo

Volltext

Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in South... von Longo, Vito, Della Corte, Carminia Maria, Russo, Alessandro, Spinnato, Francesca, Ambrosio, Francesca, Ronga, Riccardo, Marchese, Antonella, Del Giudice, Teresa, Sergi, Concetta, Casaluce, Francesca, Gilli, Marina, Montrone, Michele, Gristina, Valerio, Sforza, Vincenzo, Reale, Maria Lucia, Di Liello, Raimondo, Servetto, Alberto, Lipari, Helga, Longhitano, Claudio, Vizzini, Laura, Manzo, Anna, Cristofano, Antonella, Paolelli, Loretta, Nardone, Annalisa, De Summa, Simona, Perrone, Antonella, Bisceglia, Carmela, Derosa, Caterina, Nardone, Valerio, Viscardi, Giuseppe, Galetta, Domenico, Vitiello, Fabiana

Volltext

J-ALEX trial will crown alectinib as the standard choice for anaplastic lymphoma kinase positive untreated non-small cell lung cancer patients? von Gridelli, Cesare, Casaluce, Francesca, Sgambato, Assunta, Palazzolo, Giovanni, Maione, Paolo

Volltext

Treatment of limited-stage small cell lung cancer in the elderly, chemotherapy vs. sequential chemoradiotherapy vs. concurrent chemoradiotherapy: that’s the question von Gridelli, Cesare, Casaluce, Francesca, Sgambato, Assunta, Monaco, Fabio, Guida, Cesare

Volltext

Second-Line Treatment Options in Non–Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology von Gridelli, Cesare, Baas, Paul, Barlesi, Fabrice, Ciardiello, Fortunato, Crinò, Lucio, Felip, Enriqueta, Gadgeel, Shirish, Papadimitrakopoulou, Vali, Paz-Ares, Luis, Planchard, David, Perol, Maurice, Hanna, Nasser, Sgambato, Assunta, Casaluce, Francesca, de Marinis, Filippo

Volltext

Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown? von Sgambato, Assunta, Casaluce, Francesca, Maione, Paolo, Rossi, Antonio, Ciardiello, Fortunato, Gridelli, Cesare

Volltext

The PI3k inhibitors: new hopes in the battle against advanced NSCLC von Sacco, Paola Claudia, Maione, Paolo, Rossi, Antonio, Barecshino, Maria Anna, Sgambato, Assunta, Casaluce, Francesca, Napolitano, Alba, Palazzolo, Giovanni, Rossi, Emanuela, Ferrara, Carmine, Gridelli, Cesare

Volltext

The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes von Sgambato, Assunta, Casaluce, Francesca, Rossi, Antonio, Maione, Paolo, Sacco, Paola Claudia, Ciardiello, Fortunato, Gridelli, Cesare

Volltext

ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC: SPECIAL FOCUS ON LUNG CANCER von CASALUCE, Francesca, SGAMBATO, Assunta, MAIONE, Paolo, ROSSI, Antonio, FERRARA, Carmine, NAPOLITANO, Alba, PALAZZOLO, Giovanni, CIARDIELLO, Fortunato, GRIDELLI, Cesare

Volltext